12:00 AM
 | 
Nov 03, 2014
 |  BioCentury  |  Finance

Fresh fund, same plan

Advent sticking with investment strategy for L145.5M second life sciences fund

Advent Venture Partners plans to stick with its long-standing investment strategy for its second dedicated life sciences fund, Advent Life Sciences Fund II, which the firm closed last week with £145.5 million ($234.3 million).

"The investment strategy we put in place with the 2006 fund is the same one we applied in ALSF I and will apply in ALSF II," said the firm's Raj Parekh.

Advent closed...

Read the full 320 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >